Get Premium to unlock powerful stock data

Rock Springs Capital Management LP Buys Baxter International Inc, Xilio Therapeutics Inc, Aura Biosciences Inc, Sells Teleflex Inc, Allakos Inc, Atea Pharmaceuticals Inc

Author's Avatar
Feb 16, 2022
Article's Main Image
Baltimore, MD, based Investment company Rock Springs Capital Management LP (Current Portfolio) buys Baxter International Inc, Xilio Therapeutics Inc, Aura Biosciences Inc, Compass Therapeutics Inc, West Pharmaceutical Services Inc, sells Teleflex Inc, Allakos Inc, Atea Pharmaceuticals Inc, Bolt Biotherapeutics Inc, Bolt Biotherapeutics Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Rock Springs Capital Management LP. As of 2021Q4, Rock Springs Capital Management LP owns 128 stocks with a total value of $4.3 billion. These are the details of the buys and sells.

For the details of Rock Springs Capital Management LP's stock buys and sells, go to https://www.gurufocus.com/guru/rock+springs+capital+management+lp/current-portfolio/portfolio

These are the top 5 holdings of Rock Springs Capital Management LP
  1. Agilon Health Inc (AGL) - 7,495,000 shares, 4.74% of the total portfolio. Shares added by 5.94%
  2. Humana Inc (HUM) - 349,000 shares, 3.79% of the total portfolio. Shares added by 2.05%
  3. Align Technology Inc (ALGN) - 200,000 shares, 3.08% of the total portfolio.
  4. Intuitive Surgical Inc (ISRG) - 360,000 shares, 3.03% of the total portfolio.
  5. Insulet Corp (PODD) - 463,750 shares, 2.89% of the total portfolio. Shares added by 5.98%
New Purchase: Xilio Therapeutics Inc (XLO)

Rock Springs Capital Management LP initiated holding in Xilio Therapeutics Inc. The purchase prices were between $9.69 and $25.11, with an estimated average price of $17.08. The stock is now traded at around $14.490000. The impact to a portfolio due to this purchase was 0.45%. The holding were 1,191,094 shares as of 2021-12-31.

New Purchase: Aura Biosciences Inc (AURA)

Rock Springs Capital Management LP initiated holding in Aura Biosciences Inc. The purchase prices were between $14.76 and $24.89, with an estimated average price of $17.87. The stock is now traded at around $21.990000. The impact to a portfolio due to this purchase was 0.4%. The holding were 1,008,114 shares as of 2021-12-31.

New Purchase: Compass Therapeutics Inc (CMPX)

Rock Springs Capital Management LP initiated holding in Compass Therapeutics Inc. The purchase prices were between $2.88 and $4.08, with an estimated average price of $3.56. The stock is now traded at around $2.390000. The impact to a portfolio due to this purchase was 0.4%. The holding were 5,328,088 shares as of 2021-12-31.

New Purchase: Theseus Pharmaceuticals Inc (THRX)

Rock Springs Capital Management LP initiated holding in Theseus Pharmaceuticals Inc. The purchase prices were between $8.98 and $20.09, with an estimated average price of $15.08. The stock is now traded at around $12.900000. The impact to a portfolio due to this purchase was 0.13%. The holding were 437,329 shares as of 2021-12-31.

Added: Baxter International Inc (BAX)

Rock Springs Capital Management LP added to a holding in Baxter International Inc by 63.07%. The purchase prices were between $74.57 and $87.19, with an estimated average price of $80.52. The stock is now traded at around $85.130000. The impact to a portfolio due to this purchase was 0.57%. The holding were 733,803 shares as of 2021-12-31.

Added: Accolade Inc (ACCD)

Rock Springs Capital Management LP added to a holding in Accolade Inc by 29.69%. The purchase prices were between $21.96 and $41.12, with an estimated average price of $32.45. The stock is now traded at around $21.270000. The impact to a portfolio due to this purchase was 0.17%. The holding were 1,197,000 shares as of 2021-12-31.

Added: West Pharmaceutical Services Inc (WST)

Rock Springs Capital Management LP added to a holding in West Pharmaceutical Services Inc by 51.67%. The purchase prices were between $402.25 and $471.34, with an estimated average price of $431.11. The stock is now traded at around $379.320000. The impact to a portfolio due to this purchase was 0.17%. The holding were 45,500 shares as of 2021-12-31.

Added: Sarepta Therapeutics Inc (SRPT)

Rock Springs Capital Management LP added to a holding in Sarepta Therapeutics Inc by 21.14%. The purchase prices were between $77.28 and $99.42, with an estimated average price of $85.35. The stock is now traded at around $79.990000. The impact to a portfolio due to this purchase was 0.16%. The holding were 424,000 shares as of 2021-12-31.

Added: Xenon Pharmaceuticals Inc (XENE)

Rock Springs Capital Management LP added to a holding in Xenon Pharmaceuticals Inc by 32.29%. The purchase prices were between $24.73 and $35.4, with an estimated average price of $30.08. The stock is now traded at around $33.130000. The impact to a portfolio due to this purchase was 0.14%. The holding were 771,367 shares as of 2021-12-31.

Added: Conmed Corp (CNMD)

Rock Springs Capital Management LP added to a holding in Conmed Corp by 24.62%. The purchase prices were between $129.86 and $157.03, with an estimated average price of $141.78. The stock is now traded at around $144.100000. The impact to a portfolio due to this purchase was 0.13%. The holding were 202,500 shares as of 2021-12-31.

Sold Out: Teleflex Inc (TFX)

Rock Springs Capital Management LP sold out a holding in Teleflex Inc. The sale prices were between $289.48 and $378.74, with an estimated average price of $339.07.

Sold Out: Allakos Inc (ALLK)

Rock Springs Capital Management LP sold out a holding in Allakos Inc. The sale prices were between $8.55 and $111.89, with an estimated average price of $80.43.

Sold Out: Atea Pharmaceuticals Inc (AVIR)

Rock Springs Capital Management LP sold out a holding in Atea Pharmaceuticals Inc. The sale prices were between $7.67 and $44.59, with an estimated average price of $14.96.

Sold Out: Bolt Biotherapeutics Inc (BOLT)

Rock Springs Capital Management LP sold out a holding in Bolt Biotherapeutics Inc. The sale prices were between $4.19 and $13.97, with an estimated average price of $9.35.

Sold Out: Bolt Biotherapeutics Inc (BOLT)

Rock Springs Capital Management LP sold out a holding in Bolt Biotherapeutics Inc. The sale prices were between $4.19 and $13.97, with an estimated average price of $9.35.

Sold Out: Oak Street Health Inc (OSH)

Rock Springs Capital Management LP sold out a holding in Oak Street Health Inc. The sale prices were between $28.4 and $48.53, with an estimated average price of $37.66.



Here is the complete portfolio of Rock Springs Capital Management LP. Also check out:

1. Rock Springs Capital Management LP's Undervalued Stocks
2. Rock Springs Capital Management LP's Top Growth Companies, and
3. Rock Springs Capital Management LP's High Yield stocks
4. Stocks that Rock Springs Capital Management LP keeps buying
Rating:
0 / 5 (0 votes)
Author's Avatar
WRITTEN BY

GuruFocus Screeners

Related Articles